REAADS ANTI-CARDIOLIPIN IGG/IGM SEMI-QUANTITATIVE TEST KIT, MODEL 023-001— 510(k) K022992

Substantially Equivalent

Corgenix, Inc.

FDA 510(k) clearance K022992 for REAADS ANTI-CARDIOLIPIN IGG/IGM SEMI-QUANTITATIVE TEST KIT, MODEL 023-001, Substantially Equivalent on 2002-09-25. Applicant: Corgenix, Inc..

Clearance details

Applicant: Corgenix, Inc.
Product code: Code MID
Advisory panel: Immunology
Date received: 2002-09-09
Decision date: 2002-09-25
Decision: Substantially Equivalent
Clearance type: Special
Location: Westminster, CO, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.